Hiltunen M - Search Results

1

Down-regulation of seladin-1 increases BACE1 levels and activity through enhanced GGA3 depletion during apoptosis.

Sarajärvi T, Haapasalo A, Viswanathan J, Mäkinen P, Laitinen M, Soininen H, Hiltunen M. Sarajärvi T, et al. Among authors: hiltunen m. J Biol Chem. 2009 Dec 4;284(49):34433-43. doi: 10.1074/jbc.M109.036202. Epub 2009 Oct 8. J Biol Chem. 2009. PMID: 19815556 Free PMC article.

2

Butyrylcholinesterase K variant and apolipoprotein E4 genes do not act in synergy in Finnish late-onset Alzheimer's disease patients.

Hiltunen M, Mannermaa A, Helisalmi S, Koivisto A, Lehtovirta M, Ryynänen M, Riekkinen P Sr, Soininen H. Hiltunen M, et al. Neurosci Lett. 1998 Jun 26;250(1):69-71. doi: 10.1016/s0304-3940(98)00453-4. Neurosci Lett. 1998. PMID: 9696068

3

Linkage disequilibrium in the 13q12 region in Finnish late onset Alzheimer's disease patients.

Hiltunen M, Mannermaa A, Koivisto AM, Lehtovirta M, Helisalmi S, Ryynänen M, Riekkinen P Sr, Soininen H. Hiltunen M, et al. Eur J Hum Genet. 1999 Sep;7(6):652-8. doi: 10.1038/sj.ejhg.5200342. Eur J Hum Genet. 1999. PMID: 10482953

4

Promoter polymorphism (-491A/T) in the APOE gene of Finnish Alzheimer's disease patients and control individuals.

Helisalmi S, Hiltunen M, Valonen P, Mannermaa A, Koivisto AM, Lehtovirta M, Ryynänen M, Soininen H. Helisalmi S, et al. Among authors: hiltunen m. J Neurol. 1999 Sep;246(9):821-4. doi: 10.1007/s004150050461. J Neurol. 1999. PMID: 10525981 Clinical Trial.

5

Is the presenilin-1 E318G missense mutation a risk factor for Alzheimer's disease?

Helisalmi S, Hiltunen M, Mannermaa A, Koivisto AM, Lehtovirta M, Alafuzoff I, Ryynänen M, Soininen H. Helisalmi S, et al. Among authors: hiltunen m. Neurosci Lett. 2000 Jan 7;278(1-2):65-8. doi: 10.1016/s0304-3940(99)00891-5. Neurosci Lett. 2000. PMID: 10643802

6

The leucine (7)-to-proline (7) polymorphism in the signal peptide of neuropeptide Y is not associated with Alzheimer's disease or the link apolipoprotein E.

Helisalmi S, Valve R, Karvonen MK, Hiltunen M, Pirskanen M, Mannermaa A, Koulu M, Pesonen U, Uusitupa M, Soininen H. Helisalmi S, et al. Among authors: hiltunen m. Neurosci Lett. 2000 Jun 16;287(1):25-8. doi: 10.1016/s0304-3940(00)01126-5. Neurosci Lett. 2000. PMID: 10841982

7

Identification of a novel 4.6-kb genomic deletion in presenilin-1 gene which results in exclusion of exon 9 in a Finnish early onset Alzheimer's disease family: an Alu core sequence-stimulated recombination?

Hiltunen M, Helisalmi S, Mannermaa A, Alafuzoff I, Koivisto AM, Lehtovirta M, Pirskanen M, Sulkava R, Verkkoniemi A, Soininen H. Hiltunen M, et al. Eur J Hum Genet. 2000 Apr;8(4):259-66. doi: 10.1038/sj.ejhg.5200423. Eur J Hum Genet. 2000. PMID: 10854108

8

Genes, proteins and brain disease.

Hiltunen M, Soininen H. Hiltunen M, et al. Trends Mol Med. 2001 Sep;7(9):382-3. doi: 10.1016/s1471-4914(01)02098-6. Trends Mol Med. 2001. PMID: 11530316 No abstract available.

9

Genome-wide linkage disequilibrium mapping of late-onset Alzheimer's disease in Finland.

Hiltunen M, Mannermaa A, Thompson D, Easton D, Pirskanen M, Helisalmi S, Koivisto AM, Lehtovirta M, Ryynänen M, Soininen H. Hiltunen M, et al. Neurology. 2001 Nov 13;57(9):1663-8. doi: 10.1212/wnl.57.9.1663. Neurology. 2001. PMID: 11706108

10

Seladin-1 transcription is linked to neuronal degeneration in Alzheimer's disease.

Iivonen S, Hiltunen M, Alafuzoff I, Mannermaa A, Kerokoski P, Puoliväli J, Salminen A, Helisalmi S, Soininen H. Iivonen S, et al. Among authors: hiltunen m. Neuroscience. 2002;113(2):301-10. doi: 10.1016/s0306-4522(02)00180-x. Neuroscience. 2002. PMID: 12127087

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

398 results

Search Page

Filters